Cargando…
miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer
Our previous study demonstrated that miR-124 was downregulated in colorectal cancer (CRC) compared with normal mucosa, and the downregulated expression of miR-124 was an independent prognostic factor in CRC patients. However, the function of miR-124 in CRC patients treated with chemotherapy is curre...
Autores principales: | Xie, Xu-Qin, Wang, Mo-Jin, Li, Yuan, Lei, Lin-Ping, Wang, Ning, Lv, Zhao-Ying, Chen, Ke-Ling, Zhou, Bin, Ping, Jie, Zhou, Zong-Guang, Sun, Xiao-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200624/ https://www.ncbi.nlm.nih.gov/pubmed/32382656 http://dx.doi.org/10.1016/j.omto.2020.04.003 |
Ejemplares similares
-
miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4
por: Hu, Haili, et al.
Publicado: (2017) -
Pri-miR-124 rs531564 polymorphism and colorectal cancer risk
por: Gao, Xue-ren, et al.
Publicado: (2015) -
Inhibition of miR-96 enhances the sensitivity of colorectal cancer cells to oxaliplatin by targeting TPM1
por: Ge, Tingrui, et al.
Publicado: (2020) -
MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1
por: Zhang, Yajie, et al.
Publicado: (2016) -
The miR-124-p63 feedback loop modulates colorectal cancer growth
por: Liu, Kuijie, et al.
Publicado: (2017)